SEATTLE--(BUSINESS WIRE)--According to Coherent Market Insights, the global stem cell therapy market was valued at US$ 7,342.0 million in 2018, and is projected to exhibit a CAGR of 21.0% during the forecast period (2018 – 2026).
Key Trends and Analysis of Stem cell Therapy Market:
Increasing collaboration activities by key players is expected to drive growth of the stem cell therapy market. For instance, in August 2018, Cellect Biotechnology Ltd collaborated with Cell2in, a company based in South Korea, for improvement of stem cell quality. Under this collaboration, the companies work on developing the stem cells quality by combining Cellect technology’s platform, ApoGraft, with Cell2in’s identification technology called FreSHtracer.
Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/2848
Consistent increasing research and development activities are also expected to facilitate growth of the global stem cell therapy market. For instance, in March 2019, Emory University (USA) initiated clinical phase III trial of a stem cell therapy for the treatment of osteoarthritis, which is expected to complete in December 2021. Osteoarthritis is a disease that can damage knees, hips, hands, and joints in the spine.
Inquire before Buying @ https://www.coherentmarketinsights.com/insight/talk-to-analyst/2848
Moreover, increasing patent approvals from regulatory authorities is expected to propel the stem cell therapy market growth in the near future. For instance, in September 2017, Biocardia received patent approval from U.S. Food and Drug Administration for its CardiALLO cell therapy program. CardiALLO cell therapy is related to the preparation of mesenchymal stem cells from bone marrow stem cells.
Among regions, Europe stem cell therapy market is expected to account for the largest market share over the forecast period. This is owing to increasing number of approvals by the European Commission (EC) in the region. For instance, in March 2018, TiGenix NV and Takeda Pharmaceuticals received central marketing authorization from the European Commission for Alofisel, an allogeneic stem cell therapy which is used for treatment of complex perianal fistulas in adult patients.
Purchase this report (For Single User License) @ https://www.coherentmarketinsights.com/insight/buy-now/2848
Key Market Takeaways:
- The global stem cell therapy market is projected to witness a CAGR of 21.0% during the forecast period (2018 – 2026), owing to increasing number of product launches by key players. For instance, in November 2015, Osiris Therapeutics, Inc. launched its new product Stravix. Stravix is a viable, cryopreserved human placental tissue. Stravix is a used for surgical applications in soft tissue repair therapies.
- Among regions, Asia Pacific is expected to account for a significant share in the global stem cell therapy market, owing to increasing product launches by key players in the region. For instance, in May 2019, Sumitomo Dainippon Pharma Co., Ltd., headquartered in Osaka, Japan, launched its new product RETHIO 100 mg I.V. infusion. RETHIO is used in autologous hematopoietic stem cell transplantation to treat pediatric malignant solid tumor.
- Major players operating in the global stem cell therapy market include, Osiris Therapeutics, Inc. Novartis AG, GlaxoSmithKline Plc., MEDIPOST Co., Ltd., Anterogen Co., Ltd. Pharmicell Co., Ltd. Holostem Terapie Avanzate S.r.l. JCR Pharmaceuticals Co., Ltd. NuVasive, Inc. RTI Surgical, Inc., and Fibrocell Science, Inc.
To know the latest trends and insights prevalent in this market, click the link below:
https://www.coherentmarketinsights.com/market-insight/stem-cell-therapy-market-2848
Report Segmentation:
-
Global Stem Cell Therapy Market, By Source:
- Embryonic Stem Cells
- Adult Stem Cells
- Mesenchymal Stem Cells
- Induced Pluripotent Stem Cells
-
Global Stem Cell Therapy market, By Therapy Type:
- Allogeneic Stem Cell Therapy
- Autologous Stem Cell Therapy
-
Global Stem Cell Therapy Market, By Application:
- Gastro-Intestine Diseases
- Central Nervous System Diseases
- Cardiovascular Diseases
- Wounds and Injuries
- Eye Diseases
- Immune Therapy Diseases
- Musculoskeletal Disorders
- Others
-
Global Stem Cell Therapy Market, By End User:
- Hospitals and Clinics
- Ambulatory Surgical Centers
-
Global Stem Cell Therapy Market, By Region:
-
North America
- U.S.
- Canada
-
North America
-
Europe
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
-
Asia Pacific
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
-
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
-
Middle East
- GCC
- Israel
- Rest of Middle East
-
Africa
- South Africa
- Central Africa
- North Africa
- Company Profiles
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
